SCOPUS 정보 검색 플랫폼

Volumn 61, Issue 3, 2001, Pages 880-883

The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors

(8) Reilly, R Todd a Machiels, Jean Pascal H a Emens, Leisha A a Ercolini, Anne M a Okoye, Francesca I a Lei, Rachel Y a Weintraub, Diane a Jaffee, Elizabeth M a

a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; GENE PRODUCT; PROTEIN 3T3 NEU GEM; RECOMBINANT INTERLEUKIN 2; TRASTUZUMAB; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BREAST CANCER; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; GENE THERAPY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; B-LYMPHOCYTES; FEMALE; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE ACTIVATION; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, SCID; NEOPLASM TRANSPLANTATION; RECEPTOR, ERBB-2; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; VACCINATION;

EID: 0035116901 PISSN: 00085472 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (142)

References (20)

1
- 0032844121
- Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer
- Herceptin Multinational Investigator Study Group
- (1999) Semin. Oncol. , vol.26 , pp. 71-77
- Shak, S.¹

2
- 0032719863
- Preclinical and Phase 1 and 11 trials of rituximab
- (1999) Semin. Oncol. , vol.26 , pp. 74-78
- Maloney, D.G.¹

3
- 19244366949
- Phase 1 studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin
- (2000) J. Clin. Oncol. , vol.18 , pp. 904-914
- Baselga, J.¹ Pfister, D.² Cooper, M.R.³ Cohen, R.⁴ Burtness, B.⁵ Bos, M.⁶ D'Andrea, G.⁷ Seidman, A.⁸ Norton, L.⁹ Gunnett, K.¹⁰ Falcey, J.¹¹ Anderson, V.¹² Waksal, H.¹³ Mendelsohn, J.¹⁴

4
- 0032825577
- Combination therapy with trastuzumab (Herceptin) and cisplatin for chemoresistant metastatic breast cancer: Evidence for receptor-enhanced chemosensitivity
- (1999) Semin. Oncol. , vol.26 , pp. 89-95
- Pegram, M.D.¹ Slamon, D.J.²

5
- 0029041003
- Prevention of breast tumor development in viva by downregulation of the p185neu receptor
- (1995) Nat. Med. , vol.1 , pp. 644-648
- Katsumata, M.¹ Okudaira, T.² Samanta, A.³ Clark, D.P.⁴ Drebin, J.A.⁵ Jolicoeur, P.⁶ Greene, M.I.⁷

6
- 0034234934
- HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice
- (2000) Cancer Res. , vol.60 , pp. 3569-3576
- Reilly, R.T.¹ Gortlieb, M.B.² Ercolini, A.M.³ Machiels, J.P.⁴ Kane, C.E.⁵ Okoye, F.I.⁶ Muller, W.J.⁷ Dixon, K.H.⁸ Jaffee, E.M.⁹

7
- 0026472124
- Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease
- (1992) Proc. Natl. Acad. Sci. USA , vol.89 , pp. 10578-10582
- Guy, C.T.¹ Webster, M.A.² Schaller, M.³ Parsons, T.J.⁴ Cardiff, R.D.⁵ Muller, W.J.⁶

8
- 3543024857
- Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen
- (1986) Proc. Natl. Acad. Sci. USA , vol.83 , pp. 9129-9133
- Drebin, J.A.¹ Link, V.C.² Weinberg, R.A.³ Greene, M.I.⁴

9
- 0032851961
- Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin)
- (1999) Semin. Oncol. , vol.26 , pp. 60-70
- Sliwkowski, M.X.¹ Lofgren, J.A.² Lewis, G.D.³ Hotaling, T.E.⁴ Fendly, B.M.⁵ Fox, J.A.⁶

10
- 0034076307
- Inhibitory Fc receptors modulate in viva cytotoxicity against tumor targets
- (2000) Nat. Med. , vol.6 , pp. 443-446
- Clynes, R.A.¹ Towers, T.L.² Presta, L.G.³ Ravetch, J.V.⁴

11
- 0034234854
- Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2
- (2000) Cancer Res. , vol.60 , pp. 3384-3388
- Klapper, L.N.¹ Waterman, H.² Sela, M.³ Yarden, Y.⁴

12
- 0027370248
- Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene
- (1993) Cell. Immunol. , vol.151 , pp. 225-234
- Ioannides, C.G.¹ Fisk, B.² Fan, D.³ Biddison, W.E.⁴ Wharton, J.T.⁵ O'Brian, C.A.⁶

13
- 0028144438
- Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer
- (1994) Cancer Res. , vol.54 , pp. 16-20
- Disis, M.L.¹ Calenoff, E.² McLaughlin, G.³ Murphy, A.E.⁴ Chen, W.⁵ Groner, B.⁶ Jeschke, M.⁷ Lydon, N.⁸ McGlynn, E.⁹ Livingston, R.B.¹⁰

14
- 0029053749
- Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines
- (1995) J. Exp. Med. , vol.181 , pp. 2109-2117
- Fisk, B.¹ Blevins, T.L.² Wharton, J.T.³ Ioannides, C.G.⁴

15
- 0030657467
- High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer
- (1997) J. Clin. Oncol. , vol.15 , pp. 3363-3367
- Disis, M.L.¹ Pupa, S.M.² Gralow, J.R.³ Dittadi, R.⁴ Menard, S.⁵ Cheever, M.A.⁶

16
- 0032446987
- Genetic immunization against neu/erbB2 transgenic breast cancer
- (1998) Cancer Immunol. Immunother. , vol.47 , pp. 183-190
- Amici, A.¹ Venanzi, F.M.² Concetti, A.³

17
- 0345493645
- Targeting HER-2/neu for active-specific immunotherapy in a mouse model of spontaneous breast cancer
- (1999) Int. J. Cancer , vol.83 , pp. 393-400
- Cefai, D.¹ Morrison, B.W.² Sckell, A.³ Favre, L.⁴ Balli, M.⁵ Leunig, M.⁶ Gimmi, C.D.⁷

18
- 0032991359
- Vaccination with the extracellular domain of p185neu prevents mammary tumor development in neu transgenic mice
- (1999) Cancer Immunol. Immunother. , vol.47 , pp. 337-342
- Esserman, L.J.¹ Lopez, T.² Montes, R.³ Bald, L.N.⁴ Fendly, B.M.⁵ Campbell, M.J.⁶

19
- 12944254575
- DNA vaccination with full-length or truncated neu induces protective immunity against the development of spontaneous mammary tumors in HER-2/neu transgenic mice
- (2000) Gene Ther. , vol.7 , pp. 703-706
- Amici, A.¹ Smorlesi, A.² Noce, G.³ Santoni, G.⁴ Cappelletti, P.⁵ Capparuccia, L.⁶ Coppari, R.⁷ Lucciarini, R.⁸ Petrelli, C.⁹ Provinciali, M.¹⁰

20
- 0034660850
- Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine
- (2000) Cancer Res. , vol.60 , pp. 3782-3789
- Dakappagari, N.K.¹ Douglas, D.B.² Triozzi, P.L.³ Stevens, V.C.⁴ Kaumaya, P.T.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.